Novo Nordisk A/S
Novel Insulin Derivatives and the Medical Uses Hereof

Last updated:

Abstract:

The present invention is in the therapeutic fields of drugs for medical conditions relating to diabetes. More specifically the invention relates to novel acylated derivatives of human insulin analogues. The invention also provides pharmaceutical compositions comprising such insulin derivatives, and relates to the use of such derivatives for the treatment or prevention of medical conditions relating to diabetes.

Status:
Application
Type:

Utility

Filling date:

25 Mar 2020

Issue date:

10 Sep 2020